Call for Abstract

13th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology, will be organized around the theme “Nanomedicine: Shaping the future of next generation medicine”

NanoMed 2017 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in NanoMed 2017

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Nanomedicine seeks to deliver a valuable set of research tools and clinically useful devices. The pharmaceutical industry is developing new commercial applications that may include advanced drug delivery systems, new therapies, and Nanomaterials for Imaging and Drug Delivery. Another active and very much related area of research is the investigation of toxicity and environmental impact of nanoscale materials, since nanomedicines must be biocompatible for clinical application.

  • Track 1-1Graphene medicine
  • Track 1-2Personalized nanomedicine
  • Track 1-3Nanomedicine in theranostics
  • Track 1-4Regenerative medicine and tissue engineering
  • Track 1-5Nanomedicine for cardiovascular diseases
  • Track 1-6Nanomedicine for lung diseases
  • Track 1-7Nanomedicine for blood disorders
  • Track 1-8Nanomedicine for CNS
  • Track 1-9Nanomedicine for gastrointestinal tract (GI) diseases

Nanotechnology is the science which deals with the processes that occur at molecular level and of nanolength scale size. The major studies in the nanotechnology include nanosized particles, their function and behaviour with respect to other systems. The tremendous capabilities of nanoparticles have changed the perspective and scope of nanotechnology towards development into an adjuvant field for the remaining fields of life sciences. Nanotechnology is the ability to understand and control materials at the very smallest scales, from around 100 nm to the dimensions of single atoms; At this Nano scale the properties of these nanosized particles are vary from the conventional medicines.

  • Track 2-1Pharmaceutical nanotechnology based systems
  • Track 2-2Characterization of pharmaceutical nanotools
  • Track 2-3Engineering of pharmaceutical nanosystems
  • Track 2-4Applications of pharmaceutical nanotools
  • Track 2-5Biomedical nanotechnology
  • Track 2-6Nanotechnology and immunotherapy
  • Track 2-7RNA Nanotechnology
  • Track 2-8Nanobiotechnology

Pharmaceutical Nanotechnology deals with emerging new technologies for developing customized solutions for drug delivery systems. The drug delivery system positively impacts the pharmacokinetics of the drug or other related chemical entities in the body. In addition to this the drug delivery system also allows the drug to bind to its target receptor and influence that receptor signaling and activity. Pharmaceutical nanotechnology is helpful in the field of pharmacy as nanomaterials, and as devices like drug delivery, diagnostic, imaging and biosensor.

  • Track 3-1Nanoporous materials
  • Track 3-2Nanomaterials for drug delivery
  • Track 3-3Drug delivery research
  • Track 3-4Nanotechnology in therapeutics
  • Track 3-5Thin film drug delivery
  • Track 3-6Drug carrier & drug-loaded polymer nanoparticles
  • Track 3-7Microchannel emulsification
  • Track 3-8Nanoparticles for controlled drug delivery
  • Track 3-9MicroRNA delivery
  • Track 3-10Magnetic nanoparticles, silver nanoparticles and gold nanoparticles

Nanopharmaceuticals represent an emerging field where the sizes of the drug particle or a therapeutic delivery system work at the nanoscale. Nanopharmaceuticals offer the ability to detect diseases at much earlier stages and the diagnostic applications could build upon conventional procedures using nanoparticles. Nanopharmaceuticals represent an emerging field where the sizes of the drug particle or a therapeutic delivery system work at the nanoscale. In the pharmaceutical industry, a long standing issue is the difficulty of delivering the appropriate dose of a particular active agent to specific disease site. Nanopharmaceuticals have enormous potential in addressing this failure of traditional therapeutics which offers site-specific targeting of active agents. Such precision targeting via nanopharmaceuticals reduces toxic systemic side effects, resulting in better patient compliance.


  • Track 4-1Design of nanodrugs
  • Track 4-2Smart drug delivery technology

Novel approaches of drug delivery systems helps to enhance the availability of the drug, safety, efficacy and patient compliance. These Novel systems enable the administration of drugs in various routes and help in improving bioavailability of the drug either by changing its course of action, pharmacokinetic parameters or by the releasing patterns at the site of action. Drug delivery has now become a versatile scientific field by involving the studies of both biopharmaceutics and pharmacokinetics. These novel systems are to provide novel strategies for the delivery of biologically active drug molecules to the targeted sites at the right dose and at the right time.

  • Track 5-1Transdermal drug delivery system
  • Track 5-2Particle engineering & particulate systems
  • Track 5-3Formulation techniques
  • Track 5-4Drug loaded erythrocytes
  • Track 5-5Insitu forming biomaterials
  • Track 5-6Liposomes & hydrogels
  • Track 5-7Drug delivery techniques in neurology and neurodegenerative systems
  • Track 5-8Synthesis of nanoparticles for drug delivery

Nano drug delivery systems can be used to tune and regulate release pharmacokinetics, pharmacodynamics, solubility, immunocompatibility, cellular uptake, biodistribution and by reducing toxicity these will enhances therapeutic index of traditional pharmaceuticals. They can be used to deliver both small-molecular and macromolecular drugs. These nanoparticles mediated sustained release of drugs offer an advantage that the targeted delivery of drugs in the body is required to prevent the release of therapeutics at non-specific sites and unwanted side-effects. The conjugation of targeting moieties with drug-loaded nanoparticles can be used for receptor-mediated and targeted delivery. Such targeted nanoparticles have the characteristics of a perfect drug delivery system that tends to improve the therapeutic activity while reducing the toxic side effects of drugs.

  • Track 6-1Development of novel nanocarriers
  • Track 6-2Nanostructured materials and polymers
  • Track 6-3Polymeric nanocapsules
  • Track 6-4Biodegradable nanogels
  • Track 6-5Nanoscale systems
  • Track 6-6Tumor-specific targeting with nanocarriers
  • Track 6-7Nanocarrier-based protein/peptide delivery systems

Nanotechnology is widely used for development of paediatric medicine based on its variable characteristics. The large surface to volume ratio characteristic of nanomaterials is helpful to inhibit bacteria attachment to the organs and promote nonbacterial cell adhesion. The unique surface energetics of nanomaterials because of their significantly greater surface area compared with micron-sized materials. Because of the tissue growing properties of nanomaterials and antimicrobial properties of both nanoparticles and Nano modified surfaces have a number of applications within paediatric medicine. Some of these applications include anti-infection, tissue regeneration, drug delivery and bio-sensing.

  • Track 7-1Treatment for paediatric cancer
  • Track 7-2Ventilator-associated pneumonia (VAP)
  • Track 7-3Pharmacotherapy of paediatric HIV
  • Track 7-4Paediatric urology research
  • Track 7-5Molecular allergology
  • Track 7-6Paediatric heart disease and thrombosis
  • Track 7-7Nanotechnology in treatment of sickle cell disease
  • Track 7-8Nanotechnology for cystic fibrosis

Nanotechnology is generating a major influence on preclinical and clinical drug development. Novel combination of existing clinical treatments can instantaneously detect and kill only cancer cells without harming surrounding organs. Advancements in nanobiotechnology have led to the design of nanoparticle based new drug candidates that present a novel approach to medical diagnostics and therapeutics. The biocompatible designing of Nano devices used for drug delivery has increased the solubility and effectiveness of classical drugs, and has provided the technology required for the targeted delivery of encapsulated tissue-organ specific therapeutics.

  • Track 8-1Nano magnetic actuation
  • Track 8-2Nanofluidics
  • Track 8-3Nanoarrays & nanosensors
  • Track 8-4Nanomaterials-based drug candidates
  • Track 8-5Short interfering RNA
  • Track 8-6Nanoparticle therapeutics

Nanotechnology represents a platform for developing revolutionary changes and improvements to many different aspects of pharmaceutical manufacturing. Also, the rate of nanotechnology discovery is proceeding more rapidly than practical applications can be found. Nanotechnology offers potential in pharmaceuticals for improving drug delivery systems, medical imaging, diagnosis, cancer therapy, and regenerative medicine. Although there is no international regulation or legislation specifically for nanomedicine, it is agreed worldwide that considerably more attention should be paid to the quality, safety, and efficacy of nanotechnology-based drugs. The US FDA and the European Medicines Agency have provided several regulatory guidelines for the development of nanomedicines.

  • Track 9-1Enable major investments and advances in basic sciences to translate faster into products to benefit consumer
  • Track 9-2Protect consumers by applying best possible science to support regulatory activities and decision-making
  • Track 9-3Keep pace with and fully utilize advances in innovation
  • Track 9-4Facilitating development of innovative products that benefit consumers and patients
  • Track 9-5Regulatory aspects towards approval of nanomedicine

Nanotechnology helps us economically to build a wide range of complex molecular devices by manipulating the structures on an atomic and molecular scale. Nanotechnology may be able to synthesize many new materials and devices with at least one dimension sized from 1 to 100 nm with a wide range of applications in pharmaceuticals. Future aspects of Nanotechnology in pharmaceuticals involve applications of nanoparticles, development of nano-robots for cellular level repairing and also to develop Nano generators and Nano pore sequencing.

  • Track 10-1Multifunctional and controllable nanoparticles
  • Track 10-2Carrier/delivery system (drug or device)
  • Track 10-3Imaging agent & targeting agent
  • Track 10-4Regenerative medicine
  • Track 10-5Surgical nanorobotics and nanorobotic microbivores
  • Track 10-6Nanogenerators and nanopore sequencing

Nano materials and devices play a major role in the field of pharmaceutical nanotechnology.  Nanomaterials  exhibit  properties  remarkably  different  from the  properties  of  the  bulk  material due to the large surface area to volume ratio that increases the solubility and rate of absorption. Novel nanostructures will helpful for use as artificial tissue engineering and also help to integrate nanodevices with the nervous system that will restore vision and hearing, and build artificial limbs through the implant of new tissue. Nanotechnology is applied in the pharmaceutical industry in such areas as nanomedicine, tissue engineering, nanorobots, biosensors, biomarkers, image enhancement devices and implant technology. Investigations are currently being carried out on, among others, liposomes, dendrimers, metallic nanoparticles, polymeric nanoparticles, CNTs, quantum dots and nanofibres.

  • Track 11-1Nanotech detector for heart attacks
  • Track 11-2Super flexible chips
  • Track 11-3Creating biodegradable electrodes
  • Track 11-4Silver nanoparticles
  • Track 11-5Nanotech-powered breathalyzer
  • Track 11-6Nano Particles & nano tubes
  • Track 11-7Nano pores & quantum dots

At present, nanotechnology has been widely applied to the area of drug development. Nanoparticle-based therapeutics has the ability to overcome biological barriers and to deliver hydrophobic drugs and biologics effectively to the target sites of disease. The complexity of nanoparticles as multi-component 3D structures require careful design and engineering and reproducible scale-up and manufacturing process to achieve a consistent product. The safety and efficacy of nanoparticle-based medicines can be influenced by minor variations in multiple parameters and need to be carefully examined in preclinical and clinical examinations. Finally, nanoparticle-based medicines may have to represent additional development challenges and regulatory considerations compared with conventional medicines. Efforts are being made to produce unique category of therapeutic agents while there is generally a lack of regulatory standards in the examination of nanoparticle-based medicines.

  • Track 12-1Rapid DNA sequencing
  • Track 12-2Single-stranded genomic DNA or RNA
  • Track 12-3Organic and inorganic nano composites
  • Track 12-4Safety and risk assessment of nanotechnology

Nano-enabled medical products have made their impact on the following areas such as cancer, CNS diseases, cardiovascular disease, and infection control. Among these cancer is one of the largest therapeutic area in which nano-enabled products have made their major contributions. Cancer is a prime focus for nano pharmaceutical R&D, and companies with clinical-stage developments. The nanomedicine market is in early growth. While nano-enhanced drug delivery products are already a commercial reality, more advanced nanotech-based medical devices are still in development, although some are at the clinical testing stage. Most of the money being spent on the wider field of nanotechnology R&D comes from government and established corporations. In the nanomedicine field, pharmaceutical and specialist companies are at the forefront of research into the medical applications of nanotechnology.

  • Track 13-1Nanotechnology tools in pharmaceutical R&D
  • Track 13-2Nanotechnology drug delivery market
  • Track 13-3Investing in nanotechnology
  • Track 13-4Nano bio Business trends & latest market research
  • Track 13-5Nano pharmaceuticals & its industrial applications
  • Track 13-6Pharmaceutical nanotechnology industry statistics
  • Track 13-7Nano pharmaceutical industry and market

In 2008 more than $18 billion was invested in nanotechnology R&D by private and public sector companies worldwide with substantial portions in the areas of health and medicine. Upon ageing of population and increasing costs of healthcare, the focus is shifting from managing health to preventative measures. Hence better diagnostic Nano devices and targeted therapeutics with smart drug delivery devices will be in higher demand. Advancements in Nanotechnology will not only improve efficacy and reduce side effects of existing drugs but also will enable a faster discovery process to eliminate non-efficacious drugs with less investment and in a little time. Similarly, these advancements in nanotechnologies will shorten the drug development process and get more drugs to market quicker.

  • Track 14-1Analysis of the markets impacted by nanotechnology
  • Track 14-2Public and privately held companies in nanotechnology
  • Track 14-3Key funding entities investing in nanotechnology
  • Track 14-4Dynamic international market
  • Track 14-5Research institutes or universities